Prof. Dame Pamela Shaw joins Samsara Therapeutics to develop MND drug candidate
Autophagy biotech company Samsara Therapeutics has appointed neurologist and world-leading researcher in Amyotrophic Lateral Sclerosis (ALS)/Motor Neurone Disease (MND) Professor Dame Pamela Shaw to its scientific advisory board. Professor Shaw will help to drive the next phase of development of Samsara’s ALS/MND drug candidate SAM001, expediting its journey into the clinic and offering new hope […]